Conavi Medical (TSE:CNVI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Conavi Medical’s Novasight Hybrid System, which uniquely combines IVUS and OCT for comprehensive coronary artery imaging, has been highlighted in a peer-reviewed article for its potential to improve cardiovascular procedures. This innovative technology is currently being showcased at the TCT 2024 conference, emphasizing its promising future in enhancing patient care.
For further insights into TSE:CNVI stock, check out TipRanks’ Stock Analysis page.